Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-130 manufacturers

Filters

Filters

Filters , active

Country of origin : Israel
1 products found

pp-130

Concentrate for solution for infusion

Dossier type
CTD
Dossier status
Under development
Country of origin
Israel
GMP approvals
Israel
Comments
Indication: Platinum-resistant ovarian cancer; evaluation in combination with checkpoint inhibitors Clinical stage: Phase 2 — COMPASSION-02 trial (COM701 + nivolumab) ongoing Modality: Biologic (humanised IgG4 monoclonal antibody) Mechanism / Target: Anti-PVRIG antibody — blocks PVRIG/PVRL2 inhibitory checkpoint axis on T and NK cells; restores anti-tumour immune response; complementary to PD-1 blockade Route / form: Intravenous infusion Differentiation: First-in-class PVRIG antagonist; computationally discovered target; potential synergy with PD-1 inhibitors in immunologically cold tumours
Manufacturer #39166

Computational biology-driven oncology company developing novel immune checkpoint inhibitors. Employs AI/genomics platform to discover previously unrecognised immunological targets. Wholly owned differentiated pipeline focused on solid tumours with unmet need.
 

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.